MedPath
HSA Approval

ERYSON GRANULES 200 mg/5 ml

SIN01860P

ERYSON GRANULES 200 mg/5 ml

ERYSON GRANULES 200 mg/5 ml

June 17, 1988

BEACONS PHARMACEUTICALS PTE. LTD.

BEACONS PHARMACEUTICALS PTE. LTD.

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantBEACONS PHARMACEUTICALS PTE. LTD.
Licence HolderBEACONS PHARMACEUTICALS PTE. LTD.

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
Prescription Only
HSA Singapore Classification

Formulation Information

GRANULE, FOR SUSPENSION

ORAL

Medical Information

J01FA01

erythromycin

Manufacturer Information

BEACONS PHARMACEUTICALS PTE. LTD.

BEACONS PHARMACEUTICALS PTE. LTD.

Active Ingredients

ERYTHROMYCIN ETHYLSUCCINATE 234mg/5ml EQV ERYTHROMYCIN

200mg/5ml

Erythromycin

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.